<bill session="116" type="s" number="2252" updated="2022-11-01T13:50:25Z">
  <state datetime="2019-07-24">REFERRED</state>
  <status>
    <introduced datetime="2019-07-24"/>
  </status>
  <introduced datetime="2019-07-24"/>
  <titles>
    <title type="display">Empowering States to Address Drug Costs Act</title>
    <title type="short" as="introduced">Empowering States to Address Drug Costs Act</title>
    <title type="official" as="introduced">A bill to amend title XIX of the Social Security Act to expand the permitted uses of drug price information disclosed to States under the Medicaid drug rebate program.</title>
  </titles>
  <sponsor bioguide_id="V000128"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2019-07-24"/>
  </cosponsors>
  <actions>
    <action datetime="2019-07-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-07-24" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
    <term name="State and local government operations"/>
  </subjects>
  <amendments/>
  <summary date="2020-11-03T21:46:01Z" status="Introduced in Senate">Empowering States to Address Drug Costs Act

This bill expands the purposes for which states may use certain drug pricing information that is disclosed to them by manufacturers through the Medicaid Drug Rebate Program. Specifically, the bill allows states to use such information in furtherance of prescription drug affordability boards or state multi-payer purchasing pools.</summary>
</bill>
